1. Home
  2. MRUS vs RRR Comparison

MRUS vs RRR Comparison

Compare MRUS & RRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • RRR
  • Stock Information
  • Founded
  • MRUS 2003
  • RRR 1976
  • Country
  • MRUS Netherlands
  • RRR United States
  • Employees
  • MRUS N/A
  • RRR N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • RRR Hotels/Resorts
  • Sector
  • MRUS Health Care
  • RRR Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • RRR Nasdaq
  • Market Cap
  • MRUS 2.9B
  • RRR 3.2B
  • IPO Year
  • MRUS 2016
  • RRR 2016
  • Fundamental
  • Price
  • MRUS $44.21
  • RRR $47.78
  • Analyst Decision
  • MRUS Strong Buy
  • RRR Buy
  • Analyst Count
  • MRUS 12
  • RRR 12
  • Target Price
  • MRUS $87.92
  • RRR $60.42
  • AVG Volume (30 Days)
  • MRUS 635.1K
  • RRR 546.2K
  • Earning Date
  • MRUS 10-31-2024
  • RRR 02-05-2025
  • Dividend Yield
  • MRUS N/A
  • RRR 2.05%
  • EPS Growth
  • MRUS N/A
  • RRR N/A
  • EPS
  • MRUS N/A
  • RRR 2.72
  • Revenue
  • MRUS $35,932,000.00
  • RRR $1,906,030,000.00
  • Revenue This Year
  • MRUS N/A
  • RRR $13.51
  • Revenue Next Year
  • MRUS $57.37
  • RRR $0.92
  • P/E Ratio
  • MRUS N/A
  • RRR $17.70
  • Revenue Growth
  • MRUS N/A
  • RRR 12.99
  • 52 Week Low
  • MRUS $24.95
  • RRR $47.18
  • 52 Week High
  • MRUS $61.61
  • RRR $63.29
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 43.33
  • RRR 37.13
  • Support Level
  • MRUS $41.03
  • RRR $47.75
  • Resistance Level
  • MRUS $43.68
  • RRR $50.82
  • Average True Range (ATR)
  • MRUS 2.28
  • RRR 1.20
  • MACD
  • MRUS 0.14
  • RRR -0.10
  • Stochastic Oscillator
  • MRUS 29.61
  • RRR 6.37

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About RRR Red Rock Resorts Inc.

Red Rock Resorts Inc along with its subsidiary is a gaming, development, and management company. The company mainly develops strategically located casino and entertainment properties. It generates a majority of its revenue from Casino.

Share on Social Networks: